Luteal phase oestradiol administration in ovarian stimulation cycles with GnRH antagonist is comparable to the GnRH agonist (long) protocol

Journal of Assisted Reproduction and Genetics

Volumn 24, Issue 8, 2007, Pages 326-330

  Cunha Filho, J S ^a   Terres, L F ^a   Holanda, F ^a   Freitas, F ^a   Glitz, C ^a   Genro, V K ^a   Arbo, E ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Follicular cohort; GnRH agonist; GnRH antagonists; Homogenization; Luteal phase oestradiol

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN ANTAGONIST; LEUPRORELIN; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ADULT; ARTICLE; CELL COUNT; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; FERTILIZATION IN VITRO; HUMAN; INFERTILITY; INTRACYTOPLASMIC SPERM INJECTION; LUTEAL PHASE; MAJOR CLINICAL STUDY; OOCYTE; OVARY CYCLE; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CHORIONIC GONADOTROPIN; EMBRYO IMPLANTATION; ESTRADIOL; FEMALE; FERTILIZATION IN VITRO; GONADOTROPIN-RELEASING HORMONE; HUMANS; LEUPROLIDE; LUTEAL PHASE; OOCYTES; OVULATION INDUCTION; PREGNANCY; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 34548454508     PISSN: 10580468     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10815-007-9125-x     Document Type: Article

References (15)

1. Albano C, Smitz J, Camus M, Rietmuller-Winzen H, Van Steirteghem A, Devroey P. Comparison of different doses of gonadotropin-releasing hormone antagonist Cetrorelix during controlled ovarian hyperstimulation. Fertil Steril 1997;67:917-22.
2. European Orgalutran Study Group, Borm G, Mannaerts B. Treatment with the gonadotropin-releasing hormone antagonist ganirelix in women undergoing ovarian stimulation with recombinant follicle stimulating hormone is effective, safe and convenient: results of a controlled, randomized, multicentre trial. Hum Reprod 2000;15:1490-8.
3. European Middle East Orgalutran Study Group. Comparable clinical outcome using the GnRH antagonist ganirelix or a long protocol of the GnRH agonist triptorelin for the prevention of premature LH surges in women undergoing ovarian stimulation. Hum Reprod 2001;16:644-51.
4. Al-Inany H, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception. A Cochrane review. Hum Reprod 2002;17:874-85.
5. Olivennes F, Cunha Filho JS, Fanchin R, Bouchard P, Frydman R. The use of GnRH antagonists in ovarian stimulation. Hum Reprod Update 2002;8:279-90.
6. Klein NA, Battaglia DE, Fujimoto VY, Davis GS, Bremner WJ, Soules MR. Reproductive aging: accelerated ovarian follicular development associated with a monotropic follicle-stimulating hormone rise in normal older women. J Clin Endocrinol Metab 1996;81:1038-45.
7. Fanchin R, Cunha-Filho JS, Schonauer LM, Kadoch IJ, Cohen-Bacri P, Frydman R. Coordination of early antral follicles by luteal estradiol administration provides a basis for alternative controlled ovarian hyperstimulation regimens. Fertil Steril 2003;79(2):316-21.
8. Olivennes F, Belaisch-Allart J, Emperaire JC, Dechaud H, Alvarez S, Moreau L, et al. Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LHRH) antagonist (cetrorelix) or a depot formula of an LHRH agonist (triptorelin). Fertil Steril 2000;73(2):314-20.
9. Albano C, Felberbaum RE, Smitz J, Riethmüller-Winzen H, Engel J, Diedrich K, et al. On behalf of the European Cetrorelix Study Group Ovarian stimulation with HMG: results of a prospective randomized phase III European study comparing the luteinizing hormone-releasing hormone (LHRH)-antagonist cetrorelix and the LHRH-agonist buserelin. Hum Reprod 2000;15:526-31.
10. The North American Ganirelix Study Group, Fluker M, Grifo J, Leader A, Levy M, Meldrum D, Muasher SJ, et al. Efficacy and safety of ganirelix acetate versus leuprolide acetate in women undergoing controlled ovarian hyperstimulation. Fertil Steril 2001;75:38-45.
11. Fanchin R, Salomon L, Castelo-Branco A, Olivennes F, Frydman N, Frydman R. Luteal estradiol pre-treatment coordinates follicular growth during controlled ovarian hyperstimulation with GnRH antagonists. Hum Reprod 2003;8(12):2698-703.
12. Zeleznik AJ. Premature elevation of systemic estradiol reduces serum levels of follicle-stimulating hormone and lengthens the follicular phase of the menstrual cycle in rhesus monkeys. Endocrinology 1981;109:352-5.
13. De Ziegler D, Jaaskelainen AS, Brioschi PA, Fanchin R, Bulletti C. Synchronization of endogenous and exogenous FSH stimuli in controlled ovarian hyperstimulation (COH). Hum Reprod 1998;13:561-4.
14. Ludwig M, Katalinic A, Banz C, Schröeder AK, Löning M, Weiss JM, et al. Tailoring the GnRH antagonist cetrorelix acetate to individual patients'needs in ovarian stimulation for IVF: results of prospective, randomized study. Hum Reprod 2002;17(11):2842-5.
15. Cunha-Filho JS, Lemos N, Stein N, Laranjeira A, Passos EP. Vascular endothelial growth factor and inhibin A in follicular fluid of infertile patients who underwent in vitro fertilization with a gonadotropin-releasing hormone antagonist. Fertil Steril 2005;83(4):902-7.